Tag: TEER

ACC 2023: Quality of life improvements drive benefit for transcatheter therapy in TRILUMINATE pivotal trial

Hotly-anticipated results of the randomised TRILUMINATE pivotal trial, presented during the 2023...

One-year real-world data “promising” for transcatheter tricuspid repair

 One-year insights from the bRIGHT registry, detailing real-world results of tricuspid transcath...

TCT 2022: TEER in cardiogenic shock patients shows promise for lowering mortality and heart failure hospitalisation

Analysis of data from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) ...

Edwards’ Pascal Precision transcatheter valve repair system receives FDA approval for degenerative mitral regurgitation

Edwards Lifesciences has announced that its Pascal Precision transcatheter valve repair system for t...

“Encouraging” early results for TEER seen in bRIGHT registry

 The first analysis of findings from the bRIGHT registry, detailing real-world results of t...